Names | |
---|---|
Preferred IUPAC name
(3R,3aR,6S,6aR)-Hexahydrofuro[3,2-b]furan-3,6-diol | |
Other names
D-Isosorbide; 1,4:3,6-Dianhydro-D-sorbitol; 1,4-Dianhydrosorbitol
| |
Identifiers | |
3D model (JSmol)
|
|
ChEBI | |
ChEMBL | |
ChemSpider | |
DrugBank | |
ECHA InfoCard | 100.010.449 |
KEGG | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C6H10O4 | |
Molar mass | 146.142 g·mol−1 |
Appearance | Highly hygroscopic white flakes |
Density | 1.30 at 25 °C |
Melting point | 62.5 to 63 °C (144.5 to 145.4 °F; 335.6 to 336.1 K) |
Boiling point | 160 °C (320 °F; 433 K) at 10 mmHg |
in water (>850 g/L), alcohols and ketones | |
Pharmacology | |
None | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Clinical data | |
---|---|
Trade names | Ismotic, Isobide, others |
License data |
|
Identifiers | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.010.449 |
Isosorbide is a bicyclic chemical compound from the group of diols and the oxygen-containing heterocycles, containing two fused furan rings. The starting material for isosorbide is D-sorbitol, which is obtained by catalytic hydrogenation of D-glucose, which is in turn produced by hydrolysis of starch. Isosorbide is discussed as a plant-based platform chemical from which biodegradable derivatives of various functionality can be obtained.
In 2022, it was the 119th most commonly prescribed medication in the United States, with more than 5 million prescriptions.[1][2]